You just read:

Oasmia Pharmaceutical Announces Positive Overall Survival Results From Phase III Study of Apealea/Paclical for Treatment of Ovarian Cancer

News provided by

Oasmia Pharmaceutical AB

Apr 27, 2016, 07:00 ET